Traduction de «bureau the group of » (Anglais → Français) :

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

A rare genetic axonal peripheral sensorimotor neuropathy with an X-linked recessive inheritance pattern and the neonatal to early childhood-onset of severe, slowly progressive, distal muscle weakness and atrophy (in particular of the peroneal group)

Definition: Disorder involving persistent dissocial or aggressive behaviour (meeting the overall criteria for F91.- and not merely comprising oppositional, defiant, disruptive behaviour) occurring in individuals who are generally well integrated into their peer group. | Conduct disorder, group type Group delinquency Offences in the context of gang membership Stealing in company with others Truancy from school

Definition: A wide variety of medicaments and folk remedies may be involved, but the particularly important groups are: (a) psychotropic drugs that do not produce dependence, such as antidepressants, (b) laxatives, and (c) analgesics that may be purchased without medical prescription, such as aspirin and paracetamol. Persistent use of these substances often involves unnecessary contacts with medical professionals or supporting staff, and is sometimes accompanied by harmful physical effects of the substances. Attempts to dissuade or forbid the use of the substance are often met with resistance; for laxatives and analgesics this may be in ...[+++] spite of warnings about (or even the development of) physical harm such as renal dysfunction or electrolyte disturbances. Although it is usually clear that the patient has a strong motivation to take the substance, dependence or withdrawal symptoms do not develop as in the case of the psychoactive substances specified in F10-F19. | Abuse of:antacids | herbal or folk remedies | steroids or hormones | vitamins | Laxative habit

bureau of a political group | group bureau

Automotive Crisis Group | Future of the Automotive Industry Interregional Group | Interregional group on the Future of the Automotive Industry | Interregional Group on the Future of the Automotive Industry in our Territories

Describes a rare group of immunodeficiencies due to specific mutations in the inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma (IKBKG) or the cytochrome b-245, beta polypeptide (CYBB) genes. The clinical manifestation is my

Charcot-Marie-Tooth disease, type 4F (CMT4F) is a demyelinating CMT peripheral sensorimotor polyneuropathy. It is a rare form of CMT4 but the few reported families are from diverse ethnic groups: Lebanese Shiite Muslims, Hispanic North Americans, Nor

Bureau of the Group

The updated list was published on 19 May 2015 as a Notice from the European Commission (2015/C 162/06); it comprises eleven organisations: American Bureau of Shipping (ABS); Bureau Veritas SA — Registre international de classification de navires et d’aeronefs (BV); China Classification Society (CCS); Croatian Register of Shipping (CRS); DNV GL AS; KR (Korean Register); Lloyd’s Register Group LTD (LR); Nippon Kaiji Kyokai General Incorporated Foundation (ClassNK); Polish Register of Shipping (PRS); RINA Services S.p.A.; Russ ...[+++]ian Maritime Register of Shipping (RS).

After a full review of the Joint Transparency Register, which lists all groups and organisations wishing to influence the decision making process at the European Commission and the European Parliament, a working group of the Commission and the EP Bureau has come up with some 30 immediate improvements including strong incentives to encourage organisations to register.

Considers that the Joint Working Group should reflect the democratic balance within Parliament; believes that the working group should consider, inter alia, further alternatives relating to the opening hours of the Members’ Register and measures to encourage the use of cheaper and greener modes of transport; furthermore, calls on the working group to report back to the Committee on Budgets and the Bureau in order to achieve medium and long-term structural and organisational savings in Parliament's budget;

Question No. 621 Ms. Hélène Laverdière: With regard to the planned reductions in departmental spending for the Department of Foreign Affairs and International Trade (DFAIT) announced in Budget 2012, for fiscal years 2012-2013, 2013-2014 and 2014-2015: (a) what is the total dollar amount of reductions for each of the program activities, specifically, (i) International Policy Advice and Integration, (ii) Diplomacy and Advocacy, (iii) International Commerce, (iv) Consular Services and Emergency Management, (v) Passport Canada, (vi) Governance, Strategic Direction and Common Service Delivery; (b) what are the total reductions for full-time equivalents (FTEs) for each of the program activities, specifically, (i) International Policy Advice and ...[+++]Integration, (ii) Diplomacy and Advocacy, (iii) International Commerce, (iv) Consular Services and Emergency Management, (v) Passport Canada, (vi) Governance, Strategic Direction and Common Service Delivery; (c) what is the total dollar amount of reductions to the Corporate Social Responsibility Counsellor for the Extractive Sector; (d) what is the total dollar amount of reductions to the Office of the Assistant Deputy Minister, Afghanistan, Middle East and Maghreb, broken down by (i) Afghanistan Inter-Departmental Communications and Information Services Bureau, (ii) Director General, Afghanistan Task Force, (iii) Middle East and Maghreb Bureau; (e) what is the total dollar amount of reductions to the Office of the Assistant Deputy Minister, Americas, broken down by (i) Director General, Latin America and Caribbean, (ii) Hemispheric Policy Bureau, (iii) North American Platform Program, Executive Coordinator and Senior Advisor, (iv) North America Policy Bureau, (v) North America Programs and Operations Bureau, (vi) North American Leaders' Summit Division; (f) what is the total dollar amount of reductions to the Office of the Assistant Deputy Minister for Europe, Eurasia and Africa, broken down by (i) Africa Bureau, Director Gen ...